Aripiprazole Injection Suppliers & Bulk Manufacturers
Available Forms: Intramuscular (IM) Injection
Available Strengths: Short-acting: 9.75 mg/1.3 mL; Long-acting: 300 mg, 400 mg (monthly)
Reference Brands: Abilify(EU & US)
Category: Antipsychotropic Drugs
Aripiprazole, marketed as Abilify, is a widely used antipsychotic available in oral and injectable forms across the US and EU. Offered in strengths from 2 mg to 400 mg, it supports schizophrenia and bipolar treatment. Pharma buyers source aripiprazole in bulk from certified suppliers for mental health distribution channels.
Product Description:
Aripiprazole is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, depression adjunct, and autism-related irritability. It is available in multiple dosage forms including oral tablets (2–30 mg), orally disintegrating tablets, oral solution (1 mg/mL), and IM injections (short and long-acting). Brands like Abilify and Abilify Maintena are widely marketed in the US and EU. Long-acting injectable forms (300 mg, 400 mg) are particularly preferred in maintenance therapy. Pharmaceutical distributors and bulk buyers source aripiprazole in various formulations for hospital use, psychiatric facilities, and retail pharmacy networks. Reliable GMP-compliant manufacturers offer consistent global B2B supply.
Aripiprazole Injection — third party manufacturing & bulk supply
Aripiprazole Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Aripiprazole Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Aripiprazole Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Aripiprazole is used to treat psychiatric and neurological conditions such as schizophrenia, bipolar disorder, major depressive disorder (as an adjunct therapy), irritability associated with autism, and Tourette syndrome. It helps stabilize mood, behavior, and thought processes.
Aripiprazole is made from the active pharmaceutical ingredient aripiprazole, an atypical antipsychotic compound that acts on dopamine and serotonin receptors in the brain.
Aripiprazole is marketed under the trade name Abilify, along with other brand names depending on formulation and region.
Aripiprazole is manufactured and marketed by multiple pharmaceutical companies worldwide. The original brand Abilify was developed and marketed by Otsuka Pharmaceutical in collaboration with Bristol Myers Squibb.
The complete generic name is aripiprazole.
A well-known brand name of aripiprazole is Abilify.
Aripiprazole is manufactured in FDA-, EMA-, and MHRA-approved facilities across the USA, EU, UK, and other regulated markets, depending on the manufacturer and dosage form.
Related Products
Lithium Carbonate
Strength:
150 mg, 300 mg, 600 mg
Form: Tablets
Reference Brands: Lithobid (USA/LATAM), Priadel (EU)
View Details
Phenobarbital Sodium
Strength:
65 mg/mL, 130 mg/mL.
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
